Somani, Ally‐Khan, Sherrif Ibrahim, Michael Tassavor, Jane Yoo, and Aaron Farberg. “Use of the 40-Gene Expression Profile (40-GEP) Test in Medicare-Eligible Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s336. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/2460.